SARS-CoV-2 Antibody Signatures for Predicting the Outcome of COVID-19
Qing Lei(Huazhong University of Science and Technology), Xionglin Fan(Huazhong University of Science and Technology), Zhuqing Ouyang(Huazhong University of Science and Technology), Jun‐biao Xue(Shanghai Jiao Tong University), Yun-xiao Zheng(Shanghai Jiao Tong University), Huan Qi(Qingdao Institute of Bioenergy and Bioprocess Technology), Zhaowei Xu(Shanghai Jiao Tong University), Caizheng Yu(Huazhong University of Science and Technology), Meian He(Ministry of Ecology and Environment), Sheng‐ce Tao(Shanghai Jiao Tong University), Xuening Wang(Shanxi Medical University), He‐wei Jiang(Shanghai Jiao Tong University), Ziyong Sun(Tongji Hospital), Yandi Zhang(Liaoning Normal University), Hong Chen(Henan Normal University), Bo Zhang(Tongji Hospital), Yang Li(Chinese Academy of Sciences), Hainan Zhang(Shanghai Jiao Tong University), Feng Wang(Shanghai Jiao Tong University), Xiaosong Lin(Huazhong University of Science and Technology), Hongyan Hou(Tongji Hospital), Dan‐yun Lai(Shanghai Jiao Tong University), Jo‐Lewis Banga Ndzouboukou(Huazhong University of Science and Technology), Shujuan Guo(Shanghai Jiao Tong University), Zongjie Yao(Huazhong University of Science and Technology)
Cited by 3
Related Papers
Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries
|PLoS ONE|2018|1.2k
The laboratory tests and host immunity of COVID-19 patients with different severity of illness
|JCI Insight|2020|576
Detection of IgM and IgG antibodies in patients with coronavirus disease 2019
|Clinical & Translational Immunology|2020|415
Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005–2014
|Clinical Microbiology and Infection|2016|376
SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70
|Cellular and Molecular Immunology|2020|376